Interleukin-18 and stress

被引:92
作者
Sugama, Shuei [1 ]
Conti, Bruno [2 ]
机构
[1] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan
[2] Scripps Res Inst, Mol & Integrat Neurosci Dept, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA
关键词
IL-18; stress; neuroimmunomodulation;
D O I
10.1016/j.brainresrev.2007.11.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-18 (IL-18) is a pro-inflammatory cytokine believed to play a role in a variety of conditions and diseases including infections, autoimmunity, cancer, diabetes and atherosclerosis. IL-18 is also a possible contributor to the sickness syndrome by inducing anorexia. and sleep. Originally recognized to be produced by cells of the immune system, IL-18 is also found in endocrine tissues, including the adrenal and the pituitary glands, and in the central nervous system where it is produced by microglial and ependymal cells as well as by neurons of the medial habenular nucleus. IL-18 is produced constitutively and its levels can increase during infection but also during stress in the absence of an exogenous stimulus. IL-18 levels are elevated by activation of the hypothalamic-pituitary-adrenal (HPA) axis in a tissue specific way via differential promoter and splicing usage, and may be down-regulated by the activation of the para-sympathetic system. This suggested the possibility that IL-18 may participate in the regulation of the HPA axis or that it may have a role in mediating the CNS dependent effects on the susceptibility to or the progression of diseases. This review summarizes the evidence linking stress and IL-18 and discusses the possible implication of the neuro-immuno-modulatory action of IL-18. (C) 2008 Published by Elsevier B.V.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 127 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Ader R, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, pXV, DOI 10.1016/B978-012088576-3/50001-0
  • [3] Cloning and expression of interleukin-18 binding protein
    Aizawa, Y
    Akita, K
    Taniai, M
    Torigoe, K
    Mori, T
    Nishida, Y
    Ushio, S
    Nukada, Y
    Tanimoto, T
    Ikegami, H
    Ikeda, M
    Kurimoto, M
    [J]. FEBS LETTERS, 1999, 445 (2-3) : 338 - 342
  • [4] Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells
    Akita, K
    Ohtsuki, T
    Nukada, Y
    Tanimoto, T
    Namba, M
    Okura, T
    TakakuraYamamoto, R
    Torigoe, K
    Gu, Y
    Su, MSS
    Fujii, M
    SatohItoh, M
    Yamamoto, K
    Kohno, K
    Ikeda, M
    Kurimoto, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) : 26595 - 26603
  • [5] Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival
    Alexandrakis, MG
    Passam, FH
    Sfiridaki, K
    Moschandrea, J
    Pappa, C
    Liapi, D
    Petreli, E
    Roussou, P
    Kyriakou, DS
    [J]. LEUKEMIA RESEARCH, 2004, 28 (03) : 259 - 266
  • [6] Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO
  • [7] 2-8
  • [8] Stress and the inflammatory response: A review of neurogenic inflammation
    Black, PH
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (06) : 622 - 653
  • [9] Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
    Borovikova, LV
    Ivanova, S
    Zhang, MH
    Yang, H
    Botchkina, GI
    Watkins, LR
    Wang, HC
    Abumrad, N
    Eaton, JW
    Tracey, KJ
    [J]. NATURE, 2000, 405 (6785) : 458 - 462
  • [10] Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study
    Bosma, H
    Marmot, MG
    Hemingway, H
    Nicholson, AC
    Brunner, E
    Stansfeld, SA
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7080): : 558 - 565